George T. Wu, Ph.D.

Partner

Email : gwu@cm.law

Toll Free: 1-844-285-4263 ext. 786

Direct : 314-704-3891

Office : New York (primary), Chicago, Boston, New Jersey, Washington, DC

Dr. George Wu is an experienced intellectual property attorney who focuses his practice on biomedical-related matters and cutting-edge technologies.

He is experienced in counseling clients on patent applications as well as trademark and copyright registrations, specifically in the biotechnology, pharmaceutical, chemical, and medical device industries.

Dr. Wu also represents clients in Inter Partes Reviews at the Patent Trial and Appeal Board and 337 investigations before the International Trade Commission. Alongside 14 years of legal experience, his strong technical background in molecular and cell biology provides him with an additional perspective when advising clients.

He received his Ph.D., in Molecular Biology, from Weill Cornell Medical College in New York, 2007, and his Juris Doctor from Fordham University School of Law in New York, 2005. He received his M.S., in Microbiology and Immunology, from Stanford University, 1994, and his B.A., in Molecular & Cellular Biology, from the University of California, Berkeley, 1992.

Selected Presentations & Publications

  • Panelist, Diversity & Inclusion in Career Development, American Immigration Lawyers Association Ethics Conference, Chicago, May 3, 2019
  • Panelist, The New Reality Facing Chinese Americans During the U.S.-China Conflict, University of Chicago, March 9, 2019.
  • Panelist, The Important and Potentially Dangerous Impacts of the Economic Espionage Act and Other Related Policies, United Chinese Americans, Houston, September 22, 2018.
  • Hu, D., Liu, W., Wu, G., Wan, Y. Nuclear translocation of Skp2 facilitates its destruction in response to TGF-β signaling. Cell Cycle. 2011 January; 10(2): 1-8.
  • Liu, W., Zong, W., Wu, G., Fujita, T., Li, W., Wu, J., Wan, Y. Turnover of BRCA1 involves in radiation-induced apoptosis. PLoS ONE. 2010 December; 5(12): 1-11.
  • Fujita, T., Zhang, L., Wu, G., Xiao, X., Wan, Y. Phosphorylation of APC/Cdc27 by CKII involves in TGF-β-mediated growth inhibition. FASEB Journal. 2010 August.
  • Wu, G. Patenting biotech beyond the central dogma. Nature Biotechnology 2010 March; 28(3): 231-3.
  • Li, W., Wu, G., Wan, Y. The Dual Effects of Cdh1/APC in Myogenesis. FASEB Journal. 2007 Nov.; 21(13): 3606-17.
  • Liu, W., Wu, G., Li, W., Lobur, D., Wan, Y. Cdh1-APC Targets Skp2 for Destruction in TGF-beta-induced Growth Inhibition. Mol. Cell. Biol. 2007 April: 27(8):2967-79.
  • Wu, G., Glickstein, S., Liu, W., Fujita, T., Li, W., Yang, Q., Duvoisin, R., Wan, Y. The Anaphase-promoting Complex Coordinates the Initiation of Lens Differentiation. Mol. Biol. Cell. 2007 March; 18(3):1018-29.
*Culhane Meadows is ranked by U.S. News/Best Law Firms in Technology Law, Bankruptcy/Reorganization Law, and Information Technology Law. This website and the communications herein may be considered attorney advertising. Previous results are not a guarantee of future outcome. This website is for informational purposes only and does not constitute legal advice. The information herein is not intended to create an attorney-client or similar relationship. Please do not send us unsolicited confidential information. Whether you need legal services and which lawyer or law firm you select are important decisions that should not be based on this website alone.